Endocrine Abstracts

Somatostatin analogues are the first line therapy for patients with functioning neuroedocrine tumours. These drugs prevent the release of peptides which cause symptoms in patients with neuroendocrine tumours. Correct and proper preparation and administration of the analogues are vital in the care of patients. The somatostatin analogues not only provide relief of symptoms, benefiting the patient, but improve the quality of life for patients. The cost of the analogues to the hea...